Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk plans new study for CagriSema, targets 2026 submission
Clinical Trials Arena
Fri, 02/7/25 - 11:42 am
Tags:
Novo Nordisk, CagriSema, obesity, clinical trials
Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect
Fierce Biotech
Fri, 02/7/25 - 11:02 am
Tags:
Novo Nordisk, hemophilia A, Mim8, pediatric
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Yahoo/Reuters
Thu, 02/6/25 - 11:40 am
Tags:
Novo Nordisk, tariffs, Europe, Donald Trump
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
CNBC
Wed, 02/5/25 - 10:42 pm
Tags:
Novo Nordisk, Wegovy, earnings
Novo flunks kidney disease trial, again linking obesity prospect to neuropsychiatric side effects
Fierce Biotech
Wed, 02/5/25 - 11:21 am
Tags:
Novo Nordisk, clinical trials, diabetic kidney disease, Monlunabant
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Yahoo/Reuters
Tue, 02/4/25 - 06:11 pm
Tags:
Novo Nordisk, CagriSema
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Motley Fool
Mon, 02/3/25 - 11:55 am
Tags:
Novo Nordisk, obesity, amycretin
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
Tags:
surgery, GLP-1 agonists, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Zepbound, Mounjaro
Novo Nordisk commences fresh trials for CagriSema
Devdiscourse
Thu, 01/30/25 - 11:33 am
Tags:
Novo Nordisk, CagriSema, clinical trials, obesity
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
Healio
Tue, 01/28/25 - 09:42 pm
Tags:
Novo Nordisk, FDA, Ozempic, kidney disease
Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial
Fierce Biotech
Tue, 01/28/25 - 10:17 am
Tags:
Veru, obesity, Novo Nordisk, enobosarm
Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35
MSN/Reuters
Mon, 01/27/25 - 10:51 pm
Tags:
Minnesota, Novo Nordisk, insulin, drug pricing
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Fierce Biotech
Fri, 01/24/25 - 11:47 am
Tags:
Novo Nordisk, amycretin, obesity, clinical trials
Novo Nordisk gets BACH1, inking IMMvention deal to orchestrate attack on sickle cell disease
Fierce Biotech
Wed, 01/22/25 - 11:55 am
Tags:
Novo Nordisk, sickle cell disease, IMMvention Therapeutix
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Tags:
Novo Nordisk, Eli Lilly, GLP-1 agonists, Wegovy, Ozempic, Zepbound, Mounjaro, Alzheimer's disease, arthritis
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Fierce Pharma
Fri, 01/17/25 - 11:34 am
Tags:
Novo Nordisk, obesity, semaglutide, Wegovy, Eli Lilly, Zepbound, clinical trials
Ozempic tops new Medicare price negotiation list
Pharmaphorum
Fri, 01/17/25 - 11:10 am
Tags:
Novo Nordisk, Ozempic, Wegovy, Rybelsus, HHS, Inflation Reduction Act, Medicare
5 questions facing pharma in 2025
BioPharma Dive
Fri, 01/10/25 - 11:47 am
Tags:
Donald Trump, obesity, Novo Nordisk, Eli Lilly, vaccines, pharma stocks, regulatory, immunology
Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list
Fierce Pharma
Wed, 01/8/25 - 11:20 pm
Tags:
Novo Nordisk, Awiqli, insulin, CagriSema, Eli Lilly, Ebglyss
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
Fierce Biotech
Wed, 01/8/25 - 11:23 am
Tags:
Novo Nordisk, Valo Health, artificial intelligence, diabetes, obesity

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.